Drug Digest: Engineering LNPs Beyond the Liver for Genetic Medicines
Logo Image

Rob Woolfenden II

Rob Woolfenden II is principal engineer in the process development department at Amgen, Inc.

Articles by Rob Woolfenden II

Latest Updated Articles